시장보고서

상품코드

1650817

세계의 바이오의약품 바이오세퍼레이션 시스템 시장

Biopharmaceutical Bioseparation Systems

발행일: 2025년 02월 | 리서치사:

Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 360 Pages | 배송안내 : 1-2일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

바이오의약품 바이오세퍼레이션 시스템 세계 시장 규모는 2030년까지 326억 달러에 달할 전망

2024년에 175억 달러로 추정되는 바이오의약품 바이오세퍼레이션 시스템 세계 시장은 2024년부터 2030년까지 CAGR 10.9%로 성장하여 2030년에는 326억 달러에 달할 것으로 예상됩니다. 본 보고서에서 분석한 부문 중 하나인 크로마토그래피 기술은 CAGR 10.2%를 기록하여 분석 기간 종료 시점에 158억 달러에 도달할 것으로 예상됩니다. 기타 기술 부문의 성장률은 분석 기간 동안 CAGR 11.5%로 추정됩니다.

미국 시장 73억 달러로 추정, 중국은 CAGR 13.3%로 성장 전망

미국의 바이오의약품 바이오세퍼레이션 시스템 시장은 2024년 73억 달러로 추정됩니다. 세계 2위의 경제 대국인 중국은 2030년까지 39억 달러의 시장 규모에 도달할 것으로 예상되며, 2024-2030년 분석 기간 동안 CAGR은 13.3%입니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 9.0%와 9.3%의 CAGR을 기록할 것으로 예상됩니다. 유럽에서는 독일이 CAGR 9.8%로 성장할 것으로 예상됩니다.

세계 바이오의약품 바이오세퍼레이션 시스템 시장 - 주요 동향 및 촉진요인 정리

바이오의약품 바이오세퍼레이션 시스템은 치료용 단백질, 단클론항체, 백신 등을 포함한 바이오의약품의 생산 및 정제에 필수적인 구성요소입니다. 이러한 시스템은 복잡한 혼합물에서 생체 분자를 분리 및 정제하기 위해 크로마토그래피, 여과, 원심분리 등 다양한 기술을 사용합니다. 만성질환 및 희귀질환 치료에 효과적인 바이오의약품에 대한 수요가 증가함에 따라 효율적이고 신뢰할 수 있는 바이오 분리 시스템의 필요성이 증가하고 있습니다. 이러한 시스템은 엄격한 규제 요건의 대상이 되는 바이오의약품의 순도, 역가 및 안전성을 보장하는 데 필수적입니다. 바이오 분리 기술의 발전은 바이오의약품 제조 공정의 효율성과 확장성을 높이고 있습니다.

바이오의약품 바이오세퍼레이션 시스템 시장은 바이오의약품 산업의 확대와 첨단 바이오분리 기술의 채택 증가로 인해 크게 성장하고 있습니다. 만성질환의 확산, 인구 고령화, 맞춤형 의료에 대한 수요 증가는 바이오의약품 생산에 박차를 가하고 있습니다. 또한, 유전자 치료 및 세포 치료와 같은 새로운 치료법의 개발은 바이오 분리 기술에 새로운 도전과 기회를 가져오고 있습니다. 일회용 시스템 및 연속 처리의 사용과 같은 재료 및 방법의 혁신은 생물분리 공정의 효율성과 비용 효율성을 향상시키고 있습니다. 이러한 발전은 더 큰 규모의 고품질 바이오의약품 생산을 가능하게 하고 있습니다.

바이오의약품 바이오세퍼레이션 시스템 시장의 성장은 몇 가지 요인에 의해 주도되고 있습니다. 첫째, 만성질환의 확산과 고령화로 인해 바이오의약품에 대한 수요가 증가하고 있으며, 효율적인 바이오 분리 시스템에 대한 요구가 증가하고 있습니다. 둘째, 일회용 시스템 및 연속 처리와 같은 바이오 분리 기술의 발전으로 바이오의약품 제조의 확장성과 비용 효율성이 향상되고 있습니다. 셋째, 유전자 치료 및 세포 치료와 같은 새로운 치료법의 개발은 바이오분리에 새로운 도전과 기회를 창출하여 이 분야의 기술 혁신을 촉진하고 있습니다. 마지막으로, 바이오의약품에 대한 엄격한 규제 요건은 제품의 품질과 안전성을 보장하기 위해 첨단 생물분리 시스템의 사용을 요구하고 있습니다. 이러한 요인들이 종합적으로 바이오의약품 바이오세퍼레이션 시스템 시장의 강력한 성장에 기여하고 있습니다.

부문

기술(크로마토그래피, 기타 기술)

조사 대상 기업 사례(총 61건)

3M Company
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Alfa Laval AB
GEA Group AG
AMS Biotechnology(Europe) Ltd.(amsbio)
Biotage AB
AnteoTech
BIA Separations d.o.o.
Heinkel Drying and Separation Group
3B Pharmaceuticals GmbH
Critical Process Filtration, Inc.
Flottweg SE
Ellutia
Global Life Sciences Solutions USA LLC(Cytiva)

The global market for Biopharmaceutical Bioseparation Systems estimated at US$17.5 Billion in the year 2024, is expected to reach US$32.6 Billion by 2030, growing at a CAGR of 10.9% over the analysis period 2024-2030. Chromatography Technology, one of the segments analyzed in the report, is expected to record a 10.2% CAGR and reach US$15.8 Billion by the end of the analysis period. Growth in the Other Technologies segment is estimated at 11.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$7.3 Billion While China is Forecast to Grow at 13.3% CAGR

The Biopharmaceutical Bioseparation Systems market in the U.S. is estimated at US$7.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.9 Billion by the year 2030 trailing a CAGR of 13.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.0% and 9.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.8% CAGR.

Global Biopharmaceutical Bioseparation Systems Market - Key Trends & Drivers Summarized

Biopharmaceutical bioseparation systems are critical components in the production and purification of biopharmaceuticals, which include therapeutic proteins, monoclonal antibodies, and vaccines. These systems employ various techniques such as chromatography, filtration, and centrifugation to separate and purify biological molecules from complex mixtures. The demand for biopharmaceuticals is increasing due to their effectiveness in treating chronic and rare diseases, driving the need for efficient and reliable bioseparation systems. These systems are essential for ensuring the purity, potency, and safety of biopharmaceutical products, which are subject to stringent regulatory requirements. Advances in bioseparation technologies are enhancing the efficiency and scalability of biopharmaceutical manufacturing processes.

The biopharmaceutical bioseparation market is experiencing significant growth due to the expanding biopharmaceutical industry and the increasing adoption of advanced bioseparation techniques. The rise in the prevalence of chronic diseases, the aging population, and the growing demand for personalized medicine are fueling the production of biopharmaceuticals. Additionally, the development of novel therapies such as gene and cell therapies is creating new challenges and opportunities for bioseparation technologies. Innovations in materials and methods, such as the use of single-use systems and continuous processing, are improving the efficiency and cost-effectiveness of bioseparation processes. These advancements are enabling the production of high-quality biopharmaceuticals at larger scales.

The growth in the biopharmaceutical bioseparation systems market is driven by several factors. Firstly, the increasing demand for biopharmaceuticals, driven by the prevalence of chronic diseases and the aging population, is boosting the need for efficient bioseparation systems. Secondly, advancements in bioseparation technologies, including single-use systems and continuous processing, are enhancing the scalability and cost-effectiveness of biopharmaceutical manufacturing. Thirdly, the development of novel therapies such as gene and cell therapies is creating new challenges and opportunities for bioseparation, driving innovation in this field. Lastly, stringent regulatory requirements for biopharmaceutical products are necessitating the use of advanced bioseparation systems to ensure product quality and safety. These factors collectively contribute to the robust growth of the biopharmaceutical bioseparation systems market.

SCOPE OF STUDY:

The report analyzes the Biopharmaceutical Bioseparation Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Technology (Chromatography, Other Technologies)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 61 Featured) -

3M Company
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Alfa Laval AB
GEA Group AG
AMS Biotechnology (Europe) Ltd. (amsbio)
Biotage AB
AnteoTech
BIA Separations d.o.o.
Heinkel Drying and Separation Group
3B Pharmaceuticals GmbH
Critical Process Filtration, Inc.
Flottweg SE
Ellutia
Global Life Sciences Solutions USA LLC (Cytiva)

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
- Impact of COVID-19 on Biopharmaceutical Bioseparation Market
- Scope of Affinity Chromatography in Aiding the Vaccine Purification methodology
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
- Biopharmaceutical Bioseparation Systems - Global Key Competitors Percentage Market Share in 2024 (E)
- A Prelude to Biopharmaceutical Bioseparation Systems
- A Peek into Biopharmaceutical Manufacturing
- Downstream Processing of Biosynthetic Products - An Overview
- Bioseparation Systems - Invaluable Tools in Biopharmaceutical Manufacturing
- US Remains Market Leader; Developing Countries to Drive Market Growth
- Chromatography Leads the Pack
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Growing Biopharmaceutical Market Drives Demand for Bioseparation Systems
- Top 10 Biopharmaceutical Companies: 2023
- Biological License Application (BLA) Approvals - 2023
- Targeted Therapies Gain Momentum, Cancer Immunotherapies on the Rise
- Process Intensification Aids in Greater Productivity
- Evolution of Chromatography Applications for the Biopharmaceutical Sector
- Chromatography in Cell & Gene Therapies
- Chromatography Methods Fraught with Issues
- Growing Biosimilars Market - A Clear Advantage for Bioseparation Technologies
- Patent Expiries of Major Biopharmaceutical Drugs in the US and Europe
- Progressive Regulatory Framework Accelerates Product Approvals & Subsequently Market Revenues
- Specific Guidelines for Biosimilars in Various Countries with Year of Publication
- Biosimilars Regulatory Agencies in Select Regional Markets
- Biosimilar Approvals in the US (2023)
- Biosimilar Approvals in Europe (2023)
- High Demand for Monoclonal Antibodies Generates Significant Opportunities for Bioseparation Systems
- Downstream Processing - A Major Trend among Biopharmaceutical Manufacturers
- Chromatography - The Gold Standard Separation Technology
- Global Chromatography Market (2023): Percentage Share Breakdown of Value Sales by Chromatography Techniques for Gas Chromatography, Liquid Chromatography, Supercritical Fluid Chromatography, Thin Layer Chromatography, and Others
- Increasing Demand for Gas Chromatography in Biopharma Separation
- Superior Efficiency Drives Use of Synthetic Ligands in Affinity Chromatography
- A Comparison of Protein and Synthetic Ligands
- Pre-packed Disposable Columns in Chromatography Gain Attention
- SMBC - An Old Approach Gaining Significant Attention
- Major Advantages and Disadvantages of SMBC
- Twin-Column SMB - An Emerging Alternative to Protein A Columns
- Growing Focus on Alternatives to Protein A Chromatography
- Chiral Chromatography Increases in Popularity
- Chromatography Efficiency and Selectivity
- Mixed-Mode Chromatography
- Multimode Chromatography
- Mixed-Mode and Multimode Media Offer Cost Savings
- Flexible and Selective Chromatography Improves Biopharmaceutical Efficiencies
- Inherent Benefits of Membrane Chromatography to Drive its Use in Bioprocessing
- His-tagged purification of protein & Immobilized Metal Affinity Chromatography (IMAC)
- Growing Use of Membrane Filtration in Biopharmaceutical Manufacturing
- Downstream Production of Biopharmaceuticals: Filtration Challenges
- Evolving Membrane Functions in Filtration for the Production of mAbs
- Filtration Technology: The Future
- Membrane Adsorbers Gain Ground in Biopharmaceutical Downstream Purification
- Prospering Vaccine Market Drives Use of Ultrafiltration Techniques
- Membrane & Bioseparation
- Need for Highly Efficient Membranes Rises
- Downstream Response of Industry to Upstream Scale-Up
- Hand-powered Centrifuge setup can Diagnose Covid-19 for just a dollar a test
- Cell Disruption & Methods Gain Popularity
- Advent of Innovative Technologies Streamline and Enhance Production of Biopharmaceutical Systems
- Affinity Technologies Improve Productivity
- Nanofiber Chromatography Technology Advantageous
- Convective Media Set to Gain Growing Use
- Nanotechnology Set to Add Interesting Dimension to Biological Separation
- Rise of Magnetic Nanoparticles
- Magnetic Biological Separation: Key Steps
- Why Carbon Nanotubes are Gaining Attention
- Application of Nanoporous & Nanofiber Membranes
- Key Challenges & the Road Ahead
- Continuous Bioprocessing Holds Potential to Positively Impact Biomanufacturing
- Perfusion Gains Attention
- Use of Continuous Purification on the Rise in Viral Processes
- Introduction of Integrated Continuous Bioprocessing System Improves Productivity and Minimizes Raw Material Wastage
- Use of Continuous Processing Technique for Manufacturing Life-Saving Medicines Gains Momentum
- Demand for Sustainable Nanofiber Chromatography Mechanism Witnesses an Upward Momentum
- Use of Precipitation Technique for Purifying Therapeutic Proteins Exhibits a Surge
- Continuous Bioseparation Gains Momentum
- Single-Use Systems Play a Key Role
- Minimizing Centrifugation Steps
- Single-Use Disposable Technologies Gain Attention
- Innovative Approaches to Overcome Perennial & Existing Challenges with Process Chromatography
- Increase in Healthcare Spending Stirs Demand for Biopharmaceutical Bioseperation Systems
- World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
- Growing Preference for Personalized Medicine to Drive Market Growth
- Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019, 2021, 2023 and 2025
4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Biopharmaceutical Bioseparation Systems Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
- TABLE 2: World Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 3: World Historic Review for Biopharmaceutical Bioseparation Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 4: World 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
- TABLE 5: World Recent Past, Current & Future Analysis for Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 6: World Historic Review for Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 7: World 15-Year Perspective for Chromatography by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 8: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 9: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 10: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

UNITED STATES
- Market Facts & Figures
- Market Analytics
- TABLE 11: USA Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 12: USA Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 13: USA 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
CANADA
- TABLE 14: Canada Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 15: Canada Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 16: Canada 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
JAPAN
- TABLE 17: Japan Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 18: Japan Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 19: Japan 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
CHINA
- TABLE 20: China Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 21: China Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 22: China 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
EUROPE
- Biopharmaceutical Bioseparation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
- TABLE 23: Europe Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 24: Europe Historic Review for Biopharmaceutical Bioseparation Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 25: Europe 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
- TABLE 26: Europe Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 27: Europe Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 28: Europe 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
FRANCE
- TABLE 29: France Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 30: France Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 31: France 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
GERMANY
- TABLE 32: Germany Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 33: Germany Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 34: Germany 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
ITALY
- TABLE 35: Italy Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 36: Italy Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 37: Italy 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
UNITED KINGDOM
- TABLE 38: UK Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 39: UK Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 40: UK 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
SPAIN
- TABLE 41: Spain Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 42: Spain Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 43: Spain 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
RUSSIA
- TABLE 44: Russia Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 45: Russia Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 46: Russia 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
REST OF EUROPE
- TABLE 47: Rest of Europe Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 48: Rest of Europe Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 49: Rest of Europe 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
ASIA-PACIFIC
- Biopharmaceutical Bioseparation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
- TABLE 50: Asia-Pacific Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 51: Asia-Pacific Historic Review for Biopharmaceutical Bioseparation Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 52: Asia-Pacific 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
- TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 54: Asia-Pacific Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 55: Asia-Pacific 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
AUSTRALIA
- TABLE 56: Australia Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 57: Australia Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 58: Australia 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
INDIA
- TABLE 59: India Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 60: India Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 61: India 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
SOUTH KOREA
- TABLE 62: South Korea Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 63: South Korea Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 64: South Korea 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
REST OF ASIA-PACIFIC
- TABLE 65: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 66: Rest of Asia-Pacific Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 67: Rest of Asia-Pacific 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
LATIN AMERICA
- TABLE 68: Latin America Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 69: Latin America Historic Review for Biopharmaceutical Bioseparation Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 70: Latin America 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Geographic Region - Percentage Breakdown of Value Revenues for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
- TABLE 71: Latin America Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 72: Latin America Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 73: Latin America 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
ARGENTINA
- TABLE 74: Argentina Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 75: Argentina Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 76: Argentina 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
BRAZIL
- TABLE 77: Brazil Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 78: Brazil Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 79: Brazil 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
MEXICO
- TABLE 80: Mexico Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 81: Mexico Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 82: Mexico 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
REST OF LATIN AMERICA
- TABLE 83: Rest of Latin America Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 84: Rest of Latin America Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 85: Rest of Latin America 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
MIDDLE EAST
- TABLE 86: Middle East Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 87: Middle East Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 88: Middle East 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
AFRICA
- TABLE 89: Africa Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 90: Africa Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 91: Africa 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030

세계의 바이오의약품 바이오세퍼레이션 시스템 시장

Biopharmaceutical Bioseparation Systems

조사 대상 기업 사례(총 61건)

목차

제1장 조사 방법

제2장 주요 요약

제3장 시장 분석

제4장 경쟁

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION